Zhejiang Medicine Co Ltd Cash Flow-to-Debt Ratio
Zhejiang Medicine Co Ltd cash flow-to-debt ratio. Zhejiang Medicine Co Ltd (600216) has a Cash Flow-to-Debt Ratio of 0.24x as of September 2025, meaning its operating cash flow of CN¥690.77 Million could theoretically repay 0% of its total liabilities (CN¥2.92 Billion) in one year. Check 600216 operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Zhejiang Medicine Co Ltd (1998–2025)
Cash flow-to-debt ratio of Zhejiang Medicine Co Ltd from 1998 to 2025. Historical debt coverage capacity for Zhejiang Medicine Co Ltd across 28 annual periods. Check 600216 cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Zhejiang Medicine Co Ltd Cash Flow-to-Debt Ratio by Year (1998–2025)
Zhejiang Medicine Co Ltd cash flow-to-debt ratio by year from 1998 to 2025. Year-by-year debt coverage analysis for Zhejiang Medicine Co Ltd. For the full cash flow conversion analysis, see Zhejiang Medicine Co Ltd operating cash flow efficiency.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.63x | CN¥1.89 Billion | CN¥3.00 Billion | ▲ +50.3% |
| 2024 | 0.42x | CN¥1.22 Billion | CN¥2.93 Billion | ▲ +84.0% |
| 2023 | 0.23x | CN¥634.31 Million | CN¥2.79 Billion | ▲ +18.8% |
| 2022 | 0.19x | CN¥520.60 Million | CN¥2.72 Billion | ▼ -43.6% |
| 2021 | 0.34x | CN¥1.14 Billion | CN¥3.35 Billion | ▼ -33.3% |
| 2020 | 0.51x | CN¥1.26 Billion | CN¥2.47 Billion | ▲ +140.0% |
| 2019 | 0.21x | CN¥447.25 Million | CN¥2.11 Billion | ▼ -28.2% |
| 2018 | 0.30x | CN¥579.91 Million | CN¥1.96 Billion | ▲ +18.1% |
| 2017 | 0.25x | CN¥503.47 Million | CN¥2.01 Billion | ▲ +35.5% |
| 2016 | 0.18x | CN¥336.14 Million | CN¥1.82 Billion | ▲ +182.8% |
| 2015 | 0.07x | CN¥106.54 Million | CN¥1.63 Billion | ▼ -84.5% |
| 2014 | 0.42x | CN¥549.90 Million | CN¥1.31 Billion | ▼ -30.9% |
| 2013 | 0.61x | CN¥655.09 Million | CN¥1.08 Billion | ▼ -35.1% |
| 2012 | 0.94x | CN¥807.49 Million | CN¥860.73 Million | ▼ -17.9% |
| 2011 | 1.14x | CN¥912.75 Million | CN¥798.63 Million | ▼ -32.8% |
| 2010 | 1.70x | CN¥1.32 Billion | CN¥773.86 Million | ▲ +18.2% |
| 2009 | 1.44x | CN¥1.47 Billion | CN¥1.02 Billion | ▲ +74.1% |
| 2008 | 0.83x | CN¥1.20 Billion | CN¥1.45 Billion | ▲ +615.4% |
| 2007 | 0.12x | CN¥227.67 Million | CN¥1.97 Billion | ▲ +19.3% |
| 2006 | 0.10x | CN¥169.51 Million | CN¥1.75 Billion | ▲ +468.1% |
| 2005 | 0.02x | CN¥25.14 Million | CN¥1.48 Billion | ▼ -81.1% |
| 2004 | 0.09x | CN¥107.60 Million | CN¥1.19 Billion | ▲ +41.7% |
| 2003 | 0.06x | CN¥66.20 Million | CN¥1.04 Billion | ▲ +177.1% |
| 2002 | 0.02x | CN¥23.13 Million | CN¥1.01 Billion | ▼ -77.6% |
| 2001 | 0.10x | CN¥98.25 Million | CN¥956.66 Million | ▲ +677.9% |
| 2000 | 0.01x | CN¥10.58 Million | CN¥801.61 Million | ▲ +127.9% |
| 1999 | -0.05x | CN¥-51.90 Million | CN¥1.10 Billion | ▼ -164.3% |
| 1998 | 0.07x | CN¥57.72 Million | CN¥782.87 Million | — |